Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-396222
Filing Date
2014-11-04
Accepted
2014-11-04 16:08:54
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d796204d10q.htm 10-Q 463651
2 EX-31.1 d796204dex311.htm EX-31.1 8613
3 EX-31.2 d796204dex312.htm EX-31.2 8599
4 EX-32.1 d796204dex321.htm EX-32.1 4192
5 EX-32.2 d796204dex322.htm EX-32.2 4171
  Complete submission text file 0001193125-14-396222.txt   2881641

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT achn-20140930.xml EX-101.INS 278111
7 XBRL TAXONOMY EXTENSION SCHEMA achn-20140930.xsd EX-101.SCH 28918
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achn-20140930_cal.xml EX-101.CAL 45680
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achn-20140930_def.xml EX-101.DEF 192858
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE achn-20140930_lab.xml EX-101.LAB 248726
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achn-20140930_pre.xml EX-101.PRE 229729
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33095 | Film No.: 141193259
SIC: 2834 Pharmaceutical Preparations